ST诺泰：注射用醋酸西曲瑞克、阿戈美拉汀片取得药品注册证书

Group 1 - ST诺泰 announced the approval of the drug registration certificate for injectable acetic acid semaglutide and agomelatine tablets by the National Medical Products Administration [2] - In the fiscal year 2024, ST诺泰's revenue composition is 99.88% from the pharmaceutical manufacturing industry and 0.12% from other businesses [2]